SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-007431 to SHL TELEMEDICINE LTD (SHLT) (CIK 0001166834) (SHMLF)

SHL TELEMEDICINE LTD (SHLT) (CIK 0001166834)
Date: July 1, 2024 · CIK: 0001166834 · Accession: 0000000000-24-007431

AI Filing Summary & Sentiment

File numbers found in text: 001-41641

Date
July 1, 2024
Author
Not clearly detected
Form
UPLOAD
Company
SHL TELEMEDICINE LTD (SHLT) (CIK 0001166834)

Letter

July 1, 2024 Erez Nachtomy Chief Executive Officer SHL Telemedicine Ltd. 90 Yigal Alon Street Tel Aviv 67891 , Israel Re:SHL Telemedicine Ltd. Form 20-F for Fiscal Year Ended December 31, 2023 File No. 001-41641 Dear Erez Nachtomy: We have limited our review of your filing to the financial statements and related disclosures and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 20-F for Fiscal Year Ended December 31, 2023 Item 15. Controls and Procedures (b) Management's Annual Report on Internal Control over Financial Reporting, page 72 1.You state that this Annual Report does not include a report of management’s assessment regarding internal control over financial reporting because the company is in a transition period permitted by the SEC for newly public companies. The instructions to Item 308 of Regulation S-K permit the omission until you had filed an annual report with the Commission for the prior fiscal year. You filed an annual report for your fiscal year ended December 31,2022. Please amend your Form 20-F for the fiscal year ended December 31, 2023 to include your Management's Report on Internal Control over Financial Reporting, or advise us otherwise. Also as a related matter, when you amend your filing, please provide updated 302 certifications that properly include paragraph 4(b) and the introductory language in paragraph 4, referring to internal control over financial reporting that are now required.

July 1, 2024 Page 2 Exhibit 13 2.We note that the Section 906 certifications filed under Exhibits 13.1 and 13.2 refer to the annual report on Form 20-F for fiscal year ended December 31, 2022. Please amend your filing to provide revised Section 906 certifications that refer to the correct fiscal year end of December 31, 2023. In doing so, please refile the Form 20-F in its entirety, along with updated certifications that are currently dated and refer to the Form 20-F/A. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christie Wong at 202-551-3684 or Li Xiao at 202-551-4391 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
July 1, 2024
Erez Nachtomy
Chief Executive Officer
SHL Telemedicine Ltd.
90 Yigal Alon Street
Tel Aviv 67891 , Israel
Re:SHL Telemedicine Ltd.
Form 20-F for Fiscal Year Ended December 31, 2023
File No. 001-41641
Dear Erez Nachtomy:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Form 20-F for Fiscal Year Ended December 31, 2023
Item 15. Controls and Procedures
(b) Management's Annual Report on Internal Control over Financial Reporting, page 72
1.You state that this Annual Report does not include a report of management’s assessment
regarding internal control over financial reporting because the company is in a transition
period permitted by the SEC for newly public companies.  The instructions to Item 308
of Regulation S-K permit the omission until you had filed an annual report with the
Commission for the prior fiscal year.  You filed an annual report for your fiscal year
ended December 31,2022.  Please amend your Form 20-F for the fiscal year ended
December 31, 2023 to include your Management's Report on Internal Control over
Financial Reporting, or advise us otherwise.  Also as a related matter, when you amend
your filing, please provide updated 302 certifications that properly include paragraph 4(b)
and the introductory language in paragraph 4, referring to internal control over financial
reporting that are now required.

July 1, 2024
Page 2
Exhibit 13
2.We note that the Section 906 certifications filed under Exhibits 13.1 and 13.2 refer to the
annual report on Form 20-F for fiscal year ended December 31, 2022.  Please amend your
filing to provide revised Section 906 certifications that refer to the correct fiscal year end
of December 31, 2023.  In doing so, please refile the Form 20-F in its entirety, along with
updated certifications that are currently dated and refer to the Form 20-F/A.
            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            Please contact Christie Wong at 202-551-3684 or Li Xiao at 202-551-4391 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services